Keyphrases
K2P3.1
100%
Whole-heart
100%
PH Dependence
100%
KCNK3
75%
Atrial Fibrillation
50%
Action Potential Duration
37%
Effective Refractory Period
37%
Guinea pig Heart
25%
Antiarrhythmic Effect
25%
Sinus Rhythm
12%
Quantitative PCR
12%
Rodent Models
12%
Atrial Effective Refractory Period
12%
Atrium
12%
Isolated Cells
12%
Voltage Clamp
12%
Human Heart
12%
Ventricle
12%
Atrial Action Potential
12%
Human Tissue
12%
Action Potential
12%
Channel Inhibition
12%
Novel Therapeutic Targets
12%
K Channels
12%
Atrial Cardiomyocytes
12%
Ventricular Action Potential
12%
Refractory Period
12%
Selective Inhibitor
12%
Guinea pig
12%
Potent Inhibitor
12%
Expression Level
12%
Biochemistry, Genetics and Molecular Biology
KCNK3
100%
Atrial Fibrillation
66%
Effective Refractory Period
66%
Action Potential Duration
50%
Guinea Pig
50%
Antiarrhythmic Activity
33%
Real-Time Polymerase Chain Reaction
16%
Sinus Rhythm
16%
Refractory Period
16%
Potassium Channel
16%
Action Potential
16%
Voltage Clamp
16%
Atrial Action Potential
16%
Cardiac Muscle Cell
16%
Medicine and Dentistry
Effective Refractory Period
66%
Atrial Fibrillation
66%
Action Potential Duration
50%
Atrium
33%
Antiarrhythmic Activity
33%
Sinus Rhythm
16%
Human Tissue
16%
Action Potential
16%
Refractory Period
16%
Voltage Clamp
16%
Ventricle of Heart
16%
Real-Time Polymerase Chain Reaction
16%
Potassium Channel
16%
Antiarrhythmic Drug
16%
Cardiac Muscle Cell
16%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
100%
Antiarrhythmic Drug
75%
Guinea Pig
75%
Potassium Channel
25%
Neuroscience
Effective Refractory Period
66%
Atrial Fibrillation
66%
Action Potential
50%
Refractory Period
16%
Real-Time Polymerase Chain Reaction
16%
Potassium Channel
16%
Voltage Clamp
16%
Atrial Action Potential
16%